These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2706419)

  • 1. Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression.
    Hanrahan PS; Scrivens GA; Russell AS
    Br J Rheumatol; 1989 Apr; 28(2):147-53. PubMed ID: 2706419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.
    Gerards AH; Landewé RB; Prins AP; Bruyn GA; Goei Thé HS; Laan RF; Dijkmans BA
    Ann Rheum Dis; 2003 Apr; 62(4):291-6. PubMed ID: 12634224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of destructive rheumatoid arthritis with methotrexate.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1997 Oct; 24(10):1881-9. PubMed ID: 9330927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update.
    Weinblatt ME; Weissman BN; Holdsworth DE; Fraser PA; Maier AL; Falchuk KR; Coblyn JS
    Arthritis Rheum; 1992 Feb; 35(2):129-37. PubMed ID: 1734901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis.
    Wendt T; Eidner T; Bräunig E; Hein G
    Eur J Med Res; 1999 Oct; 4(10):442-8. PubMed ID: 10527958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
    Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
    Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study.
    Weinblatt ME; Kaplan H; Germain BF; Block S; Solomon SD; Merriman RC; Wolfe F; Wall B; Anderson L; Gall E
    Arthritis Rheum; 1994 Oct; 37(10):1492-8. PubMed ID: 7945475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study.
    Mielants H; Veys EM; Van der Straeten C; Ackerman C; Goemaere S
    J Rheumatol; 1991 Jul; 18(7):978-83. PubMed ID: 1920332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate treatment of rheumatoid arthritis: effects on radiological progression.
    Reykdal S; Steinsson K; Sigurjónsson K; Brekkan A
    Scand J Rheumatol; 1989; 18(4):221-6. PubMed ID: 2799303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE study 2-year results.
    Fleischmann RM; Halland AM; Brzosko M; Burgos-Vargas R; Mela C; Vernon E; Kremer JM
    J Rheumatol; 2013 Feb; 40(2):113-26. PubMed ID: 23322466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis.
    Keystone EC; van der Heijde D; Kavanaugh A; Kupper H; Liu S; Guérette B; Mozaffarian N
    J Rheumatol; 2013 Sep; 40(9):1487-97. PubMed ID: 23818718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study).
    van Aken J; Heimans L; Gillet-van Dongen H; Visser K; Ronday HK; Speyer I; Peeters AJ; Huizinga TW; Allaart CF
    Ann Rheum Dis; 2014 Feb; 73(2):396-400. PubMed ID: 23334213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.
    van Dongen H; van Aken J; Lard LR; Visser K; Ronday HK; Hulsmans HM; Speyer I; Westedt ML; Peeters AJ; Allaart CF; Toes RE; Breedveld FC; Huizinga TW
    Arthritis Rheum; 2007 May; 56(5):1424-32. PubMed ID: 17469099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of methotrexate on radiographic progression in rheumatoid arthritis: a sixty-month prospective study.
    Drosos AA; Tsifetaki N; Tsiakou EK; Timpanidou M; Tsampoulas C; Tatsis CK; Kotoulas K; Moutsopoulos HM
    Clin Exp Rheumatol; 1997; 15(3):263-7. PubMed ID: 9177920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term methotrexate therapy for rheumatoid arthritis.
    Scully CJ; Anderson CJ; Cannon GW
    Semin Arthritis Rheum; 1991 Apr; 20(5):317-31. PubMed ID: 2068577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial.
    Soubrier M; Puéchal X; Sibilia J; Mariette X; Meyer O; Combe B; Flipo RM; Mulleman D; Berenbaum F; Zarnitsky C; Schaeverbeke T; Fardellone P; Dougados M
    Rheumatology (Oxford); 2009 Nov; 48(11):1429-34. PubMed ID: 19741011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.
    Konijn NPC; van Tuyl LHD; Boers M; den Uyl D; Ter Wee MM; van der Wijden LKM; Bultink IEM; Kerstens PJSM; Voskuyl AE; van Schaardenburg D; Nurmohamed MT; Lems WF
    Rheumatology (Oxford); 2017 Sep; 56(9):1586-1596. PubMed ID: 28859326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.
    Maini RN; Breedveld FC; Kalden JR; Smolen JS; Furst D; Weisman MH; St Clair EW; Keenan GF; van der Heijde D; Marsters PA; Lipsky PE;
    Arthritis Rheum; 2004 Apr; 50(4):1051-65. PubMed ID: 15077287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extension.
    Keystone EC; Breedveld FC; van der Heijde D; Landewé R; Florentinus S; Arulmani U; Liu S; Kupper H; Kavanaugh A
    J Rheumatol; 2014 Jan; 41(1):5-14. PubMed ID: 24241487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can treatment with methotrexate influence the radiological progression of rheumatoid arthritis?
    Drosos AA; Karantanas AH; Psychos D; Tsampoulas C; Moutsopoulos HM
    Clin Rheumatol; 1990 Sep; 9(3):342-5. PubMed ID: 2261733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.